Liquidia (LQDA) Net Income (QoQ) (2020 - 2026)
Liquidia (LQDA) Net Income (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Liquidia | 6.38 Bn | 6.10 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.31% |
| Mar 31, 2026 | 263.33% |
| Dec 31, 2025 | 109.71% |
| Sep 30, 2025 | -43.60% |
| Jun 30, 2025 | -172.09% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | 48.80% |
| Sep 30, 2024 | 19.41% |
| Jun 30, 2024 | 23.48% |
| Mar 31, 2024 | -344.30% |
| Dec 31, 2023 | 11.97% |
| Sep 30, 2023 | 41.20% |
| Jun 30, 2023 | -71.05% |
| Mar 31, 2023 | -504.35% |
| Dec 31, 2022 | 73.52% |
| Sep 30, 2022 | -35.00% |
| Jun 30, 2022 | 9.30% |
| Mar 31, 2022 | -37.92% |
| Dec 31, 2021 | 16.50% |
| Sep 30, 2021 | -72.54% |